Evidence of p53-induced apoptosis in cancer cells exposed to taxol [2]

In Vitro Cellular and Developmental Biology - Animal

Volumn 34, Issue 6, 1998, Pages 434-435

  Bachman, C A ^a   Bills, D A ^a   Majumdar, S K ^a  

^a LAFAYETTE COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER; CANCER CELL; CANCER CHEMOTHERAPY; HUMAN; HUMAN CELL; LETTER;

EID: 0032443524     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-998-0072-3     Document Type: Letter

References (20)

1. 1. K. Bhalla A. M. Ibrado E. Toukina 1993 Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells Leukemia 7 563 568 8096557 1:STN:280:DyaK3s3hvVaktg%3D%3D Bhalla, K.; Ibrado, A. M.; Toukina, E., et al. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7:563–568; 1993.
2. 2. L. T. Chuang E. Lotzova J. Heath 1994 Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol Cancer Res. 54 1286 1291 7907000 1:CAS:528:DyaK2cXitVyis7g%3D Chuang, L. T.; Lotzova, E.; Heath, J., et al. Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol. Cancer Res. 54:1286–1291; 1994.
3. 3. K. L. Donaldson G. L. Goolsby A. F. Wahl 1994 Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle Int. J. Cancer 57 847 855 7911457 10.1002/ijc.2910570614 1:CAS:528:DyaK2cXmt1Wisr0%3D Donaldson, K. L.; Goolsby, G. L.; Wahl, A. F. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int. J. Cancer 57:847–855; 1994.
4. 4. P. Fernandez R. Rotello Z. Rangini 1994 Expression of a specific marker of avian programmed cell death in both apoptosis and necrosis Proc. Natl. Acad. Sci. USA 91 8652 8655 10.1073/pnas.91.18.8641 Fernandez, P.; Rotello, R.; Rangini, Z., et al. Expression of a specific marker of avian programmed cell death in both apoptosis and necrosis. Proc. Natl. Acad. Sci. USA 91:8652–8655; 1994.
5. 5. T. F. Fujiwara E. A. Grimm T. Mukhopadhyay 1993 A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis Cancer Res. 53 4129 4133 8395976 1:CAS:528:DyaK3sXms1aju7c%3D Fujiwara, T. F.; Grimm, E. A.; Mukhopadhyay, T., et al. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res. 53:4129–4133; 1993.
6. 6. R. M. R. Gangemi M. Tiso C. Marchetti 1995 Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death Cancer Chemother. Pharmacol. 36 385 392 7634380 1:CAS:528:DyaK2MXoslarsr4%3D Gangemi, R. M. R.; Tiso, M.; Marchetti, C., et al. Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother. Pharmacol. 36:385–392; 1995.
7. 7. Y. Ho Y. Wang J. Lin 1996 Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells Mol. Carcinog. 16 20 31 8634091 10.1002/(SICI)1098-2744(199605)16:1<20::AID-MC4>3.0.CO;2-S 1:CAS:528:DyaK28XjtF2qt7c%3D Ho, Y.; Wang, Y.; Lin, J. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol. Carcinog. 16:20–31; 1996.
8. 8. S. K. Majumdar J. Andreassi M. Metzger 1994 Response of murine erythroleukemia cells to the anticancer drug, taxol Cell Biol. Int. 480 565 565 Majumdar, S. K.; Andreassi, J.; Metzger, M., et al. Response of murine erythroleukemia cells to the anticancer drug, taxol. Cell Biol. Int. 480:565; 1994.
9. 9. Majumdar, S. K.; Bachman, C. Evidence of apoptosis and necrosis in taxol treated murine erythroleukemia cells. Mol. Biol. Cell 7:194a; 1996.
10. 10. S. K. Majumdar B. Welchel C. Bachman 1996 Evidence of p53-dependent toxicity of taxol, an anti-cancer drug, on cultured murine erythroleukemia cells In Vitro Cell. Dev. Biol. 32 62A 63A Majumdar, S. K.; Welchel, B.; Bachman, C. Evidence of p53-dependent toxicity of taxol, an anti-cancer drug, on cultured murine erythroleukemia cells. In Vitro Cell. Dev. Biol. 32:62A-63A; 1996.
11. 11. L. Milas N. R. Hunter B. Kurdoglu 1995 Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol Cancer Chemother. Pharmacol. 35 297 303 7828272 1:CAS:528:DyaK2MXltlGrsrc%3D Milas, L.; Hunter, N. R.; Kurdoglu, B., et al. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother. Pharmacol. 35:297–303; 1995.
12. 12. L. Milas L. C. Stephens R. E. Meyn 1994 Relation of apoptosis to cancer therapy In Vivo 8 665 674 7727712 1:STN:280:DyaK2M3ksVOqtA%3D%3D Milas, L.; Stephens, L. C.; Meyn, R. E. Relation of apoptosis to cancer therapy. In Vivo 8:665–674; 1994.
13. 13. Oncogene Research Products. Wild-type p53-activated fragment ELISA product sheet. Cambridge, MA: 1996.
14. 14. E. K. Rowinsky R. C. Donehower R. W. Tucker 1988 Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol Cancer Res. 48 4093 4099 2898289 1:CAS:528:DyaL1cXkvVGrurc%3D Rowinsky, E. K.; Donehower, R. C.; Tucker, R. W. Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res. 48:4093–4099; 1988.
15. 15. J. J. Ryan M. F. Clarke 1994 Alteration of p53 conformation and induction of apoptosis in a murine erythroleukemia cell line by dimethylsulf-oxide Leuk. Res. 18 617 621 8065163 10.1016/0145-2126(94)90043-4 1:CAS:528:DyaK2cXmt1Olsro%3D Ryan, J. J.; Clarke, M. F. Alteration of p53 conformation and induction of apoptosis in a murine erythroleukemia cell line by dimethylsulf-oxide. Leuk. Res. 18:617–621; 1994.
16. 16. L. Schwartz S. Smith M. Jones 1993 Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. USA. 90 980 984 8430112 10.1073/pnas.90.3.980 1:CAS:528:DyaK3sXhsVCitrk%3D Schwartz, L.; Smith, S.; Jones, M., et al. Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. USA. 90:980–984; 1993.
17. 17. K. Seiter E. J. Feldman F. Traganos 1995 Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study of paclitaxel Leukemia 9 1961 1983 7475290 1:STN:280:DyaK28%2FntFWmsw%3D%3D Seiter, K.; Feldman, E. J.; Traganos, F., et al. Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study of paclitaxel. Leukemia 9:1961–1983; 1995.
18. 18. L. A. Speicher L. Barone K. D. Tew 1992 Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma lines Cancer Res. 52 4433 4440 1353706 1:CAS:528:DyaK38XmtVCltbg%3D Speicher, L. A.; Barone, L.; Tew, K. D. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma lines. Cancer Res. 52:4433–4440; 1992.
19. 19. R. B. Tishler D. M. Lamppu S. Park 1995 Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53 Cancer Res. 55 6021 6025 8521385 1:CAS:528:DyaK2MXhtVShtL7J Tishler, R. B.; Lamppu, D. M.; Park, S., et al. Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. Cancer Res. 55:6021–6025; 1995.
20. 20. B. C. Trauth H. Wittor E. Rubmann 1994 Two non-radioactive immunoassays for the measurement of apoptotic cell death Boehringer Mannheim Biochemicals Indianapolis, IN Trauth, B. C.; Wittor, H.; Rubmann, E. Two non-radioactive immunoassays for the measurement of apoptotic cell death. Indianapolis, IN: Boehringer Mannheim Biochemicals; 1994.